This brand name is authorized in United States. It is also authorized in Cyprus, France, South Africa, Turkey.
The drug ETHYOL contains one active pharmaceutical ingredient (API):
1
|
UNII
M487QF2F4V - AMIFOSTINE
|
|
Amifostine is a prodrug that is dephosphorylated by alkaline phosphatase in tissues to a pharmacologically active free thiol metabolite. This metabolite is believed to be responsible for the reduction of the cumulative renal toxicity of cisplatin and for the reduction of the toxic effects of radiation on normal oral tissues. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V03AF05 | Amifostine | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FR | Base de données publique des médicaments | 62371126 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8680885579055 |
| US | FDA, National Drug Code | 66220-017, 76310-017 |
| ZA | Health Products Regulatory Authority | 30/34/0234 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.